List of SBIR/STTR awards granted to Ting Therapeutics
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Ting Therapeutics in December, 2019 for $220,653.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DC018463-01 | Phase I | 220,653 | December 9, 2019 | |||||||
A SBIR Phase II contract was awarded to Ting Therapeutics in December, 2021 for $566,238.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44DC018463-02A1 | Phase II | 566,238 | December 1, 2021 | |||||||
A SBIR Phase II contract was awarded to Ting Therapeutics in August, 2022 for $621,419.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44DC018762-02A1 | Phase II | 621,419 | August 1, 2022 | |||||||
A SBIR Phase I contract was awarded to Ting Therapeutics in April, 2020 for $205,736.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DC018762-01 | Phase I | 205,736 | April 1, 2020 | |||||||
A SBIR Phase I contract was awarded to Ting Therapeutics in July, 2020 for $242,322.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DC019065-01 | Phase I | 242,322 | July 17, 2020 |
